Clinical trial
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood
NCT04751760 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 20, 2021
- Completion date
- April 20, 2026
- Enrollment
- 1,376 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
allergy and immunology